- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 122.17M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $226.84M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $248.55M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $233.44M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $328.65M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $714.99M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $738.09M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.31B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.34B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $746.42M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $940.75M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.69B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.74B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 117.54M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $24.99M |
| Capex | Q1 2025 · Mar 31, 2024 | $665K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $50.33M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $358.95M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $346.34M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.12 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.12 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $31.02M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $43.73M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$14.39M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$8.93M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $167.03M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $48.93M |
| Revenue | Q1 2025 · Mar 31, 2024 | $215.96M |